| EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
25.040 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
YWHAZ |
YWHAZ: 14-3-3 protein zeta/delta |
25.040 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
ACP1 |
ACP1: Low molecular weight phosphotyrosine protein phosphatase |
25.040 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SYK |
SYK: Tyrosine-protein kinase SYK |
25.040 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
25.040 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
25.040 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
25.040 |
Evidence |
|
| ATF6 |
ATF6: Cyclic AMP-dependent transcription factor ATF-6 alpha |
CREBBP |
CREBBP, CBP: CREB-binding protein |
25.040 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
STAM |
STAM, STAM1: Signal transducing adapter molecule 1 |
25.040 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
25.040 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
25.040 |
Evidence |
|
| LCP1 |
LCP1, PLS2: Plastin-2 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
25.040 |
Evidence |
|
| KIT |
KIT: Mast/stem cell growth factor receptor precursor |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
25.040 |
Evidence |
|
| CTSL |
CTSL: Cathepsin L precursor |
CTSB |
CTSB, CPSB: Cathepsin B precursor |
25.040 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
NRBP1 |
NRBP1, BCON3, NRBP: Nuclear receptor-binding protein |
25.040 |
Evidence |
|
| JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
25.040 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
CCND2 |
CCND2: G1/S-specific cyclin-D2 |
25.030 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PRKX |
PRKX, PKX1: Serine/threonine-protein kinase PRKX |
25.030 |
Evidence |
|
| EEF1B2 |
EEF1B2, EEF1B, EF1B: Elongation factor 1-beta |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
25.030 |
Evidence |
|
| LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
24.960 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
24.960 |
Evidence |
|
| RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
24.960 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
24.960 |
Evidence |
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
24.960 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
CD47 |
CD47, MER6: Leukocyte surface antigen CD47 precursor |
24.960 |
Evidence |
|